Funder
the National Natural Science Foundation of China
the Natural Science Foundation of Gansu Province
Medical Innovation and Development Project of Lanzhou University
the Lanzhou Science and Technology Bureau Project
Cuiying Scientific Training Program for Undergraduates of Lanzhou University Second Hospital
Cuiying Graduate Supervisor Applicant Training Program
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Bok S, Shin DY, Yallowitz AR, Eiseman M, Cung M, Xu R et al (2020) MEKK2 mediates aberrant ERK activation in neurofibromatosis type I. Nat Commun 11(1):5704
2. Jiang C, McKay RM, Le LQ (2021) Tumorigenesis in neurofibromatosis type 1: role of the microenvironment. Oncogene 40(39):5781–5787
3. Arnold SS, Payne JM, Lorenzo J, North KN, Barton B (2018) Preliteracy impairments in children with neurofibromatosis type 1. Dev Med Child Neurol 60(7):703–710
4. Hyman SL, Arthur Shores E, North KN (2006) Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 48(12):973–977
5. Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M (2003) Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet 40(10):e109